Previous Close | 10.13 |
Open | 10.32 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 10.09 - 10.40 |
52 Week Range | 7.51 - 18.93 |
Volume | |
Avg. Volume | 122,540 |
Market Cap | 270.033M |
Beta (5Y Monthly) | 1.54 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.94 |
Earnings Date | Nov 07, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 15.20 |
VALENCIA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its third quarter 2024 financial results after the close of the U.S. financial markets on Thursday, November 7, 2024. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, November 8, 2024, a
While not a mind-blowing move, it is good to see that the AVITA Medical, Inc. ( NASDAQ:RCEL ) share price has gained...